170 related articles for article (PubMed ID: 36124685)
1. Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors.
Kashani E; Schnidrig D; Gheinani AH; Ninck MS; Zens P; Maragkou T; Baumgartner U; Schucht P; Rätsch G; Rubin MA; ; Berezowska S; Ng CKY; Vassella E
Neuro Oncol; 2023 Apr; 25(4):662-673. PubMed ID: 36124685
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells.
Liu H; Chen C; Zeng J; Zhao Z; Hu Q
PLoS One; 2021; 16(7):e0253522. PubMed ID: 34197482
[TBL] [Abstract][Full Text] [Related]
3. Cell Cycle-Related FAM64A Could be Activated by TGF-β Signaling to Promote Glioma Progression.
Fu M; Zhang J; Zhang L; Feng Y; Fang X; Zhang J; Wen W; Hua W; Mao Y
Cell Mol Neurobiol; 2023 Aug; 43(6):2975-2987. PubMed ID: 37081231
[TBL] [Abstract][Full Text] [Related]
4. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
[TBL] [Abstract][Full Text] [Related]
5. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
Chen CW; Yang CH; Lin YH; Hou YC; Cheng TJ; Chang ST; Huang YH; Chung ST; Chio CC; Shan YS; Cheng HC; Chang WT
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917452
[TBL] [Abstract][Full Text] [Related]
6. Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.
Kjellman C; Olofsson SP; Hansson O; Von Schantz T; Lindvall M; Nilsson I; Salford LG; Sjögren HO; Widegren B
Int J Cancer; 2000 May; 89(3):251-8. PubMed ID: 10861501
[TBL] [Abstract][Full Text] [Related]
7. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
[TBL] [Abstract][Full Text] [Related]
8. TGF-β-induced miR10a/b expression promotes human glioma cell migration by targeting PTEN.
Liu S; Sun J; Lan Q
Mol Med Rep; 2013 Dec; 8(6):1741-6. PubMed ID: 24100613
[TBL] [Abstract][Full Text] [Related]
9. Anthocyanidins inhibit epithelial-mesenchymal transition through a TGFβ/Smad2 signaling pathway in glioblastoma cells.
Ouanouki A; Lamy S; Annabi B
Mol Carcinog; 2017 Mar; 56(3):1088-1099. PubMed ID: 27649384
[TBL] [Abstract][Full Text] [Related]
10. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
11. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
12. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
14. miR-4286 is Involved in Connections Between IGF-1 and TGF-β Signaling for the Mesenchymal Transition and Invasion by Glioblastomas.
Ho KH; Chen PH; Shih CM; Lee YT; Cheng CH; Liu AJ; Lee CC; Chen KC
Cell Mol Neurobiol; 2022 Apr; 42(3):791-806. PubMed ID: 33025417
[TBL] [Abstract][Full Text] [Related]
15. Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma.
Kawataki T; Naganuma H; Sasaki A; Yoshikawa H; Tasaka K; Nukui H
Neuropathology; 2000 Sep; 20(3):161-9. PubMed ID: 11132930
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
17. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1, FGF-2, and receptor mRNA expression in suture mesenchyme and dura versus underlying brain in fusing and nonfusing mouse cranial sutures.
Gosain AK; Recinos RF; Agresti M; Khanna AK
Plast Reconstr Surg; 2004 May; 113(6):1675-84. PubMed ID: 15114129
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway.
He X; Liu Z; Peng Y; Yu C
Biochem Biophys Res Commun; 2016 Jan; 469(4):1041-8. PubMed ID: 26682928
[TBL] [Abstract][Full Text] [Related]
20. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]